TOX3 mutations in breast cancer

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The TOX3 gene is located on chromosome 16q12, a region frequently altered in breast cancer.
• While 16q12 alterations are common, the specific role of TOX3 in breast cancer biology remains largely unknown.
• This study represents the first investigation into the significance of TOX3 mutations in breast cancer.

Purpose of the Study:

• To screen the TOX3 gene for mutations in a cohort of breast tumors.
• To determine the frequency and potential impact of TOX3 mutations in breast cancer.
• To assess the relevance of TOX3 mutations in the context of known 16q12 copy number changes in breast cancer.

Main Methods:

• Screening of the TOX3 gene for mutations in 133 primary breast tumors.
• Identification and characterization of detected mutations, including missense and in-frame deletions.
• Analysis of mutation frequency and correlation with genomic alterations in the 16q12 region.

Main Results:

• Four mutations in TOX3 were identified in six out of 133 primary breast tumors, yielding a mutation frequency of 4.5%.
• The identified mutations included three missense mutations and one in-frame deletion of 30 base pairs.
• One potentially deleterious missense mutation (Leu129Phe in exon 3) was detected in both genomic DNA and cDNA of a tumor.
• Despite common copy number changes at 16q12, TOX3 mutations were found at a low frequency.

Conclusions:

• Mutations in the TOX3 gene occur infrequently in breast tumors.
• The specific role of TOX3 in breast cancer pathogenesis requires further investigation.
• These findings highlight the need for continued research into TOX3's contribution to breast cancer biology.